Dicerna Pharmaceuticals to Present at 2009 Biologics Drug Delivery & Beyond Conference
9/21/2009 9:01:11 AM
More...
|
Dicerna Pharmaceuticals to Present at Upcoming Conferences
9/2/2009 9:13:03 AM
More...
|
Dicerna Pharmaceuticals Scientific Founder to Present Data Demonstrating Dual Inhibitory Function of Aptamer-Dicer Substrate siRNA Conjugates at Oligonucleotide Therapeutics Conference
8/3/2009 9:29:35 AM
More...
|
Archemix Corporation and Dicerna Pharmaceuticals to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics
7/21/2009 6:53:02 AM
More...
|
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
7/8/2009 8:52:59 AM
More...
|
Dicerna Pharmaceuticals to Present at Upcoming RNAi-Focused Scientific Conferences
6/4/2009 9:00:19 AM
More...
|
Dicerna Pharmaceuticals to Present at Upcoming Conferences
5/13/2009 9:24:43 AM
More...
|
Dicerna Pharmaceuticals to Present at the Second Annual Biotechnology Industry Organization (BIO) National Venture Conference
3/24/2009 9:23:03 AM
More...
|
Dicerna Pharmaceuticals Secures Exclusive Worldwide Right to Sublicense the Dicer Substrate Technology RNAi Platform
3/18/2009 7:33:06 AM
More...
|
Dicerna Pharmaceuticals Appoints C. Ronald Kahn, M.D., Vice Chairman of Joslin Diabetes Center, to its Scientific Advisory Board
1/29/2009 9:24:29 AM
More...
|
|